Voxilaprevir is a medication used to treat chronic hepatitis C virus (HCV) infection. It works by blocking the viral enzymes that HCV needs to replicate itself. It is a direct-acting antiviral (DAA) and is used in combination with other DAAs, such as sofosbuvir, to treat HCV. Voxilaprevir is usually taken in tablet form once daily for 12 or 24 weeks, depending on the strain of HCV, and is generally well-tolerated. Common side effects include headache, fatigue, nausea, and diarrhea.
Voxilaprevir is an antiviral medication used in combination with other medications to treat chronic hepatitis C virus (HCV) infection in adults. Here's a breakdown of its key aspects:
Condition:
- Voxilaprevir targets chronic HCV infection, a liver disease caused by the hepatitis C virus [1].
Mechanism of Action:
- It belongs to a class of drugs called direct-acting antivirals (DAAs) specifically categorized as NS3/4A protease inhibitors [1, 2].
- Viruses rely on specific proteins for replication. Voxilaprevir inhibits the NS3/4A protease, a vital enzyme the hepatitis C virus needs to replicate within the host cells [2]. By blocking this enzyme, voxilaprevir disrupts the virus's ability to reproduce, hindering the spread of the infection.
Use in Combination Therapy:
- Voxilaprevir is not typically used alone. It's most effective when combined with other DAAs to create a treatment regimen tailored to the specific type of HCV infection [1, 3].
- A doctor will determine the most appropriate combination therapy based on factors like the patient's genotype (strain) of the virus, treatment history, and liver function.
Important Considerations:
- Voxilaprevir is a prescription medication and should only be taken under a doctor's supervision [1].
- Common side effects include fatigue, headache, nausea, and diarrhea [1].
- Voxilaprevir can interact with other medications, so it's crucial to inform your doctor about all medications, supplements, and herbal products you're taking [4].
- It may not be suitable for everyone, particularly people with severe liver impairment or pregnant women [1].